Last reviewed · How we verify
Liposome-entrapped Mitoxantrone Hydrochloride Injection
Liposome-entrapped Mitoxantrone Hydrochloride Injection is a Small molecule drug developed by CSPC ZhongQi Pharmaceutical Technology Co., Ltd.. It is currently in Phase 1 development. Also known as: PLM60.
At a glance
| Generic name | Liposome-entrapped Mitoxantrone Hydrochloride Injection |
|---|---|
| Also known as | PLM60 |
| Sponsor | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy (PHASE2)
- A Study to Evaluate the Safety and Efficacy of PLM60 in Advanced HCC (PHASE1)
- A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Liposome-entrapped Mitoxantrone Hydrochloride Injection CI brief — competitive landscape report
- Liposome-entrapped Mitoxantrone Hydrochloride Injection updates RSS · CI watch RSS
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd. portfolio CI
Frequently asked questions about Liposome-entrapped Mitoxantrone Hydrochloride Injection
What is Liposome-entrapped Mitoxantrone Hydrochloride Injection?
Liposome-entrapped Mitoxantrone Hydrochloride Injection is a Small molecule drug developed by CSPC ZhongQi Pharmaceutical Technology Co., Ltd..
Who makes Liposome-entrapped Mitoxantrone Hydrochloride Injection?
Liposome-entrapped Mitoxantrone Hydrochloride Injection is developed by CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (see full CSPC ZhongQi Pharmaceutical Technology Co., Ltd. pipeline at /company/cspc-zhongqi-pharmaceutical-technology-co-ltd).
Is Liposome-entrapped Mitoxantrone Hydrochloride Injection also known as anything else?
Liposome-entrapped Mitoxantrone Hydrochloride Injection is also known as PLM60.
What development phase is Liposome-entrapped Mitoxantrone Hydrochloride Injection in?
Liposome-entrapped Mitoxantrone Hydrochloride Injection is in Phase 1.
Related
- Manufacturer: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. — full pipeline
- Also known as: PLM60
- Compare: Liposome-entrapped Mitoxantrone Hydrochloride Injection vs similar drugs
- Pricing: Liposome-entrapped Mitoxantrone Hydrochloride Injection cost, discount & access